Quantcast
Last updated on April 18, 2014 at 17:24 EDT

Latest John Heymach Stories

2014-02-05 12:28:35

New Members Contribute Expertise and Vision to LUNGevity's Research Program WASHINGTON, Feb. 5, 2014 /PRNewswire-USNewswire/ -- LUNGevity Foundation, one of the nation's premier lung cancer research foundations, announces two key additions to its Scientific Advisory Board: Dr. Julie Brahmer of Johns Hopkins and Dr. John Heymach of MD Anderson Cancer Center. The Scientific Advisory Board is an integral part of the foundation, guiding LUNGevity's funding of research into early detection...

2011-04-04 17:02:41

UT MD Anderson scientists find new biomarkers for erlotinib treatment Two sets of gene expression profiles predict response to a common lung cancer drug for patients that have no guiding indicators for their treatment now, scientists from The University of Texas MD Anderson Cancer Center report at the AACR 102nd Annual Meeting. "The only way we have to predict erlotinib's treatment benefit for patients now is by checking for certain mutations and amplifications of the epidermal growth factor...